Targeted Oncology4d
The Targeted Pulse: A Review of Last Month’s FDA Prominent Actions and Key Data Updates Advancing Treatment Across Disease Types
David Sallman, MD, discusses recent breakthroughs in the field of myelodysplastic syndromes (MDS). Specifically, investigators have gained a better understanding of MDS in order to design more ...
Targeted Oncology12d
Investigational Studies in MDS: Exploring Promising Therapies
In the field of myelodysplastic syndromes (MDS), there are a number of investigational studies designed with the hope of ...